Emergent Biosolutions Stock Probability of Future Stock Price Finishing Over 8.3
| EBS Stock | USD 8.30 0.15 1.84% |
Emergent |
Emergent Biosolutions Target Price Odds to finish over 8.3
The tendency of Emergent Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 8.30 | 90 days | 8.30 | about 74.25 |
Based on a normal probability distribution, the odds of Emergent Biosolutions to move above the current price in 90 days from now is about 74.25 (This Emergent Biosolutions probability density function shows the probability of Emergent Stock to fall within a particular range of prices over 90 days) .
Considering the 90-day investment horizon the stock has the beta coefficient of 2.73 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Emergent Biosolutions will likely underperform. Additionally Emergent Biosolutions has an alpha of 0.5551, implying that it can generate a 0.56 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Emergent Biosolutions Price Density |
| Price |
Predictive Modules for Emergent Biosolutions
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Emergent Biosolutions. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Emergent Biosolutions Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Emergent Biosolutions is not an exception. The market had few large corrections towards the Emergent Biosolutions' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Emergent Biosolutions, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Emergent Biosolutions within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.56 | |
β | Beta against Dow Jones | 2.73 | |
σ | Overall volatility | 1.06 | |
Ir | Information ratio | 0.1 |
Emergent Biosolutions Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Emergent Biosolutions for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Emergent Biosolutions can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Emergent Biosolutions had very high historical volatility over the last 90 days | |
| The company reported the last year's revenue of 1.05 B. Reported Net Loss for the year was (760.5 M) with profit before taxes, overhead, and interest of 290.1 M. | |
| Emergent Biosolutions has about 642.6 M in cash with (206.3 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 7.28. | |
| Roughly 58.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from thelincolnianonline.com: iShares Emergent Food and AgTech Multisector ETF To Go Ex-Dividend on December 17th |
Emergent Biosolutions Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Emergent Stock often depends not only on the future outlook of the current and potential Emergent Biosolutions' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Emergent Biosolutions' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 51.2 M | |
| Cash And Short Term Investments | 111.7 M |
Emergent Biosolutions Technical Analysis
Emergent Biosolutions' future price can be derived by breaking down and analyzing its technical indicators over time. Emergent Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Emergent Biosolutions. In general, you should focus on analyzing Emergent Stock price patterns and their correlations with different microeconomic environments and drivers.
Emergent Biosolutions Predictive Forecast Models
Emergent Biosolutions' time-series forecasting models is one of many Emergent Biosolutions' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Emergent Biosolutions' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Emergent Biosolutions
Checking the ongoing alerts about Emergent Biosolutions for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Emergent Biosolutions help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Emergent Biosolutions had very high historical volatility over the last 90 days | |
| The company reported the last year's revenue of 1.05 B. Reported Net Loss for the year was (760.5 M) with profit before taxes, overhead, and interest of 290.1 M. | |
| Emergent Biosolutions has about 642.6 M in cash with (206.3 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 7.28. | |
| Roughly 58.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from thelincolnianonline.com: iShares Emergent Food and AgTech Multisector ETF To Go Ex-Dividend on December 17th |
Additional Tools for Emergent Stock Analysis
When running Emergent Biosolutions' price analysis, check to measure Emergent Biosolutions' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Emergent Biosolutions is operating at the current time. Most of Emergent Biosolutions' value examination focuses on studying past and present price action to predict the probability of Emergent Biosolutions' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Emergent Biosolutions' price. Additionally, you may evaluate how the addition of Emergent Biosolutions to your portfolios can decrease your overall portfolio volatility.